Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

AlgoRx brings in $65mm with Series C round

Executive Summary

Pain management company AlgoRx Pharmaceuticals raised $65mm through a Series C financing led by new investor Advent International. Returning backers InterWest Partners, JPMorgan Partners, and Sofinnova Ventures participated in the oversubscribed round along with additional new investors SR One, Pacific Rim Ventures, Index Ventures, Lehman Brothers Healthcare Fund, Hunt Ventures, EGS Healthcare Capital Partners, Piper Jaffray Ventures, NIF Ventures, Axiom Venture Partners, Cogene Biotech Ventures, and William Harris Investors.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies